Filter
472
Filtered Results: 472
Text search:
booster
Featured
Recommendations
38
New Publications
100
Language
Document type
No document type
212
Guidelines
110
Studies & Reports
56
Fact sheets
28
Manuals
20
Strategic & Response Plan
17
Training Material
10
Situation Updates
7
Brochures
5
Infographics
3
Resource Platforms
2
Videos
2
Countries / Regions
India
31
Global
22
South Africa
16
Germany
10
Western and Central Europe
9
Philippines
8
Namibia
8
Brazil
8
Africa
8
Congo, Democratic Republic of
7
Mozambique
7
Ukraine
7
Senegal
6
Tanzania
6
Argentina
6
Latin America and the Carribbean
6
Zambia
5
Colombia
5
Nigeria
4
Uganda
4
Lesotho
4
East and Southern Africa
4
Ghana
3
Kenya
3
Rwanda
3
Myanmar / Burma
3
Liberia
2
Zimbabwe
2
Nepal
2
Indonesia
2
Benin
2
Botswana
2
Chile
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
Venezuela
2
Eastern Europe
2
Burkina Faso
1
Sierra Leone
1
Ethiopia
1
Niger
1
Haiti
1
Syria
1
Bangladesh
1
Switzerland
1
Ecuador
1
Madagascar
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Russia
1
Moldova
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
78
Women & Child Health
28
Public Health
21
Key Resources
8
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
COVID-19
103
TB
26
HIV
23
Mental Health
20
Refugee
16
Polio
14
Rapid Response
14
NTDs
13
Pharmacy
12
Conflict
11
Caregiver
10
Ebola
5
Natural Hazards
5
AMR
5
Planetary Health
5
NCDs
5
Disability
2
Cholera
2
Global Health Education
2
Health Financing Toolbox
2
Zika
1
Specific Hazards
1
Social Ethics
1
El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.
El documento provee algunas consideraciones sobre su utilidad e indicaciones definidas por el MSPS en nuestro país. Adicionalmente, incluye anexos y material fotográfico de las experiencias de campo, los cuales permiten complementar los
contenidos que se desarrollan en la presente publicación
La presente guía tiene además como objetivo, ser un respaldo y no una camisa de fuerza para los médicos, pues pretendemos con ella proveer evidencia sólida respecto a los riesgos, beneficios o consecuencias que puede generar la toma de una decisión en pacientes con tuberculosis. Como lo propone...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
Report by the Director-General 22 May 2022
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst...
first issued 18 August 2022
This document contains summary information on the latest projections from the IHME model on COVID-19
in Brazil. The model was run on July 15, 2022, with data through July 13, 2022.
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
